News
- 01/09/2020HONEUR’s new Interactive Patient Similarity Analysis and Visualisation Tool was accepted and published at EHA’s (European Haematology Association) 25th annual congress in June 2020. As every patient is unique, the tool i... Read more
- 17/12/2019We're delighted to welcome six more data partners to join the HONEUR collaborative network of he Janssen Pharmaceutical Companies of Johnson & Johnson. HONEUR (Haematology Outcomes Network in Europe) is a J... Read more
- 15/06/2019Objective Enabling the use of distributed statistics across federated data models Results Using real world patient haematology data we were able to demonstrate identical results from the two analyses performed using t... Read more
- 12/04/2019Improving results for patients by realising the transformational potential of Real World Data BEERSE, BELGIUM, 11 April 2019 - The Janssen Pharmaceutical Companies of Johnson & Johnson have announced today t... Read more
- 05/10/2018We are pleased to announce that we have signed the accession agreement to project HONEUR with Prof. Hajek from the Registry of Monoclonal Gammopathies (RMG) in the Czech Republic. The RMG, which is funded by the Czech My... Read more